Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Astellas Pharma Inc. (ALPMY) had Cash Flow from Financial Activities of $-2.67B for the most recently reported fiscal year, ending 2026-03-31.
| Income Statement Financials | |
$14.12B |
|
$1.92B |
|
$2.70B |
|
$11.42B |
|
$11.59B |
|
$2.53B |
|
$-39.90M |
|
$2.49B |
|
$2.49B |
|
$1.92B |
|
$1.92B |
|
$1.92B |
|
$1.92B |
|
$2.53B |
|
$3.81B |
|
1.79B |
|
1.79B |
|
$1.07 |
|
$1.07 |
|
| Balance Sheet Financials | |
$9.38B |
|
$2.37B |
|
$14.16B |
|
$23.54B |
|
$8.04B |
|
$2.11B |
|
$3.42B |
|
$11.46B |
|
$12.08B |
|
$2.59B |
|
$12.08B |
|
1.79B |
|
| Cash Flow Statement Financials | |
$3.70B |
|
$-440.37M |
|
|
Cash Flow from Financial Activities |
$-2.67B |
$1.24B |
|
$1.86B |
|
$615.34M |
|
-- |
|
$-898.25M |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|